Social bias in artificial intelligence algorithms designed to improve cardiovascular risk assessment relative to the Framingham Risk Score: a protocol for a systematic review

被引:0
|
作者
Garcha, Ivneet [1 ]
Phillips, Susan Paula [2 ]
机构
[1] Queens Univ, Med, Kingston, ON, Canada
[2] Queens Univ, Dept Family Med, Kingston, ON, Canada
来源
BMJ OPEN | 2023年 / 13卷 / 05期
关键词
primary care; preventive medicine; social medicine; cardiology;
D O I
10.1136/bmjopen-2022-067638
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionCardiovascular disease (CVD) prevention relies on timely identification of and intervention for individuals at risk. Risk assessment models such as the Framingham Risk Score (FRS) have been shown to over-estimate or under-estimate risk in certain groups, such as socioeconomically disadvantaged populations. Artificial intelligence (AI) and machine learning (ML) could be used to address such equity gaps to improve risk assessment; however, critical appraisal is warranted before ML-informed clinical decision-making is implemented.Methods and analysisThis study will employ an equity-lens to identify sources of bias (ie, race/ethnicity, gender and social stratum) in ML algorithms designed to improve CVD risk assessment relative to the FRS. A comprehensive literature search will be completed using MEDLINE, Embase and IEEE to answer the research question: do AI algorithms that are designed for the estimation of CVD risk and that compare performance with the FRS address the sources of bias inherent in the FRS? No study date filters will be imposed on the search, but English language filters will be applied. Studies describing a specific algorithm or ML approach that provided a risk assessment output for coronary artery disease, heart failure, cardiac arrhythmias (ie, atrial fibrillation), stroke or a global CVD risk score, and that compared performance with the FRS are eligible for inclusion. Papers describing algorithms for the diagnosis rather than the prevention of CVD will be excluded. A structured narrative review analysis of included studies will be completed.Ethics and disseminationEthics approval was not required. Ethics exemption was formally received from the General Research Ethics Board at Queen's University. The completed systematic review will be submitted to a peer-reviewed journal and parts of the work will be presented at relevant conferences.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Polygenic Risk Score for Cardiovascular Diseases in Artificial Intelligence Paradigm: A Review
    Khanna, Narendra N.
    Singh, Manasvi
    Maindarkar, Mahesh
    Kumar, Ashish
    Johri, Amer M.
    Mentella, Laura
    Laird, John R.
    Paraskevas, Kosmas I.
    Ruzsa, Zoltan
    Singh, Narpinder
    Kalra, Mannudeep K.
    Fernandes, Jose Fernandes E.
    Chaturvedi, Seemant
    Nicolaides, Andrew
    Rathore, Vijay
    Singh, Inder
    Teji, Jagjit S.
    Al-Maini, Mostafa
    Isenovic, Esma R.
    Viswanathan, Vijay
    Khanna, Puneet
    Fouda, Mostafa M.
    Saba, Luca
    Suri, Jasjit S.
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (46)
  • [2] Cardiovascular Risk Assessment in a Local Manufacturing Industry by Applying the Framingham Risk Score
    Flores, N.
    Avitia, R. L.
    Barreras C, O. E.
    Reyna, M. A.
    Nava, M. L.
    2017 GLOBAL MEDICAL ENGINEERING PHYSICS EXCHANGES/PAN AMERICAN HEALTH CARE EXCHANGES (GMEPE/PAHCE), 2017,
  • [3] Cardiovascular Risk In Psoriasis: A Population Based Analysis with Assessment of the Framingham Risk Score
    Veetil, Bharath Manu Akkara
    Matteson, Eric L.
    Maradit-Kremers, Hilal
    McEvoy, Marian T.
    Crowson, Cynthia S.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S729 - S729
  • [4] Cardiovascular Risk Assessment in HIV Infected Patients: Framingham or Score?
    Oliveira, Joana Isabel
    Lau, Eva
    Santos, Ana Cristina
    Serrao, Rosario
    Sarmento, Antonio
    Carvalho, Davide
    Freitas, Paula
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [5] CARDIOVASCULAR RISK ASSESSMENT USING THE FRAMINGHAM SCORE IN ARTERIAL HYPERTENSION
    Adamu, U.
    Abdullahi, A.
    Waziri, D.
    Indogesit, O. I.
    JOURNAL OF HYPERTENSION, 2015, 33 : E402 - E402
  • [6] Mitigating the risk of artificial intelligence bias in cardiovascular care
    Mihan, Ariana
    Pandey, Ambarish
    Van Spall, Harriette G. C.
    LANCET DIGITAL HEALTH, 2024, 6 (10): : e749 - e754
  • [7] A systematic review of trustworthy and explainable artificial intelligence in healthcare: Assessment of quality, bias risk, and data fusion
    Albahri, A. S.
    Duhaim, Ali M.
    Fadhel, Mohammed A.
    Alnoor, Alhamzah
    Baqer, Noor S.
    Alzubaidi, Laith
    Albahri, O. S.
    Alamoodi, A. H.
    Bai, Jinshuai
    Salhi, Asma
    Santamaria, Jose
    Ouyang, Chun
    Gupta, Ashish
    Gu, Yuantong
    Deveci, Muhammet
    INFORMATION FUSION, 2023, 96 : 156 - 191
  • [8] Assessment of cardiovascular risk in Tunisia: applying the Framingham risk score to national survey data
    Saidi, O.
    Malouche, D.
    O'Flaherty, M.
    Ben Mansour, N.
    Skhiri, H. A.
    Ben Romdhane, H.
    Bezdah, L.
    BMJ OPEN, 2016, 6 (11):
  • [9] Cardiovascular Risk in Psoriasis: A Population-Based Analysis with Assessment of the Framingham Risk Score
    Myasoedova, Elena
    Veetil, Bharath Manu Akkara
    Matteson, Eric L.
    Kremers, Hilal Maradit
    McEvoy, Marian T.
    Crowson, Cynthia S.
    SCIENTIFICA, 2013, 2013
  • [10] ASSESSMENT OF RISK OF BIAS IN ARTIFICIAL INTELLIGENCE-BASED IMAGING MODELS IN INFLAMMATORY BOWEL DISEASE - A SYSTEMATIC REVIEW
    Liu, Xiaoxuan
    Reigle, James
    Prasath, Surya
    Dhaliwal, Jasbir
    GASTROENTEROLOGY, 2023, 164 (06) : S1166 - S1167